Clinical Trial Update: Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life [Phase 3]

View source ↗

Summary

Phase 3 trial update examining sirolimus for congenital vascular malformations to improve quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Malformations

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Vascular Malformations | Phase 3 | Status: UNKNOWN